Q517--Contingency Chemotherapy Compounding Services for Louis A Johnson VA Medical Center

Solicitation

This solicitation is for Contingency Chemotherapy Compounding Services for the Louis A. Johnson VA Medical Center in Clarksburg, WV. The government requires a contractor to provide these services in the event the VA's internal IV room is shut down. The anticipated performance period is 5 years, with a Firm Fixed Price contract structure (Base year + 4 option years).

• Provide all chemotherapy agents, IV tubing, closed system drug transfer devices, and other necessary items.

• Aseptically compound hazardous chemotherapy agents based on patient-specific orders.

• Supply all drugs.

• Compounded orders must be shipped via courier or overnight mail to ensure delivery prior to the infusion date.

• Contractor must supply Safety Data Sheets (SDS) for all products upon arrival on VA property.

• Comply with all applicable records management laws and regulations, including NARA policies and Federal Records Act.

• Maintain records created for Government use and deliver them as required.

• Provide current and future certification reports for sterile compounding areas and hoods, including action plans for any failures.

• Have a contingency backup plan for the compounding facility.

• Contract Type: Firm Fixed Price

• Period of Performance: Base Year (Aug 27, 2026 – Aug 26, 2027) + 4 Option Years (through Aug 26, 2031).

• All responsible sources may submit an offer.

• The Government may award based on the initial offer without discussion.

• Contractors must be registered in the SAM Database prior to award.

• Not specified in this document.

• The Louis A. Johnson VA Medical Center is located at 1 Medical Center Drive, Clarksburg, WV 26301.

• Orders will be submitted via VA secure network or fax, with VA staff confirming receipt.

• Billing is based on the amount of medication utilized per patient.

• Compounding must be performed at an FDA 503A compliant facility and meet USP 797, USP 800, and Federal Law standards.

• The solicitation number is 36C24526Q0356.

• Response Date/Time: June 12, 2026, 15:00 Eastern Time.

Statement of Work (SOW) / Performance Work Statement (PWS)

To provide contingency chemotherapy compounding services for the VA Clarksburg Inpatient Pharmacy in the event of an IV room shutdown.

• Provide all chemotherapy agents, IV Tubing, closed system drug transfer devices, and other necessary items.

• Aseptically compound all Hazardous Chemotherapy Agents based on patient-specific orders.

• Supply all drugs.

• Receive orders via VA secure network or fax, with confirmation via phone or email.

• Transport compounded orders via Courier or overnight mail to ensure receipt prior to infusion date/time.

• Include shipping costs for all orders, including weekend deliveries.

• Invoice for billable units of medication utilized.

• Compounding must be done at an FDA 503A compliant facility.

• Adhere to all state and federal laws.

• Compounding, labeling, and expiration dating based on USP 797, USP 800, and Federal Law.

• Provide current and future certification reports for sterile compounding areas and hoods.

• Develop and provide action plans for any deficiencies and testing results showing corrections.

• Maintain a contingency backup plan for facility disruptions (certification issues, equipment malfunction, natural disasters, etc.).

• Period of Performance: Base Year (August 27, 2026 – August 26, 2027) plus four Option Years through August 26, 2031.

• Delivery Location: Louis A. Johnson Medical Center, Clarksburg, WV.

• Provide three (3) copies of each Safety Data Sheet (SDS) for every product upon arrival.

• Comply with all applicable records management laws and regulations, including NARA policies and the Federal Records Act.

• Contractor and subcontractors must handle Federal records in accordance with federal law and agency policies.

• LAJVAMC owns all data and records produced under the contract.

• Contractor employees must complete LAJVAMC-provided records management training.

Sources Sought Notice

This notice is a market research tool for the Louis A. Johnson VA Medical Center (LAJVAMC) to identify contractors capable of providing contingency hazardous chemotherapy compounding services. The LAJVAMC's Inpatient Pharmacy requires a backup contractor to handle hazardous compounding in the event their primary IV room is shut down. This notice is for informational and planning purposes to assist the government in developing its acquisition strategy.

• Provide contingency hazardous chemotherapy compounding services.

• Services are needed in the event of an IV room shutdown.

• A solicitation is not currently available. This is a Sources Sought Notice only.

• The North American Industry Classification System (NAICS) Code for this service is 456110.

• Interested contractors must submit a capability statement via email to sylvia.honesty@va.gov.

• Responses are due no later than March 25, 2026, at 3:00 p.m. Eastern Standard Time.

• Respondents will not be notified of the results of the evaluation.

• Small businesses interested must provide at least 51 percent of the services rendered.

• Responses are strictly voluntary and do not guarantee participation in a future RFQ process.

• All interested parties will be required to respond separately to any future solicitation.

• Information gathered may significantly influence the acquisition strategy.

• The attached document is a Statement of Work (SOW) for Contingency Chemotherapy Compounding Services.